Epidermal Langerhans Cells are specialized immune cells residing in the epidermis, the outermost layer of the skin. As dendritic cells, they are vital components of the skin's immune defense system, serving as the first line of defense against invading pathogens. Langerhans cells are strategically positioned in the epidermal layers, where they function as antigen-presenting cells, capturing and processing antigens from the skin environment. Upon encountering potential threats, these cells migrate to regional lymph nodes to initiate immune responses and activate T cells. The role of Langerhans cells extends beyond infection defense; they are also involved in immunoregulation, wound healing, and maintaining skin tolerance. Additionally, Langerhans cells play a crucial role in skin allergies and autoimmune disorders, influencing the balance between immune activation and tolerance. Their ability to recognize and respond to various antigens makes them essential for skin health. Malfunctions in Langerhans cell activity have been implicated in skin diseases, including psoriasis and allergic dermatitis. Research continues to explore the intricate functions of Langerhans cells, providing insights into skin immunology and potential therapeutic strategies for skin-related conditions.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy